Eolo Pharma - Crunchbase Company Profile & Funding

Q: Who invested in Eolo Pharma?

Eolo Pharma has 2 investors including Ficus Capital And Cites.

Q: When was the last funding round for Eolo Pharma?

Eolo Pharma closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Eolo Pharma raised to date?

Eolo Pharma has raised obfuscated.

Overview

Eolo Pharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Eolo Pharma

CB Rank

27864

Eolo Pharma focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases.

Founded

obfuscation

Private

Venture - Series Unknown

Wilmington, Delaware, United States

1-10

eolo-pharma.com/

Biopharma

Biotechnology

Health Care

Pharmaceutical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Pía Garat: CEO
Carlos Batthyány: CMO

Details

Legal Name

EOLO USA, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Carlos Batthyány, Carlos Escande, María Pía Garat, Virginia López

About the Company

Pharma develops molecular drugs intended to cure chronic inflammation. It specializes in the research and development of medicines that target the molecular and cellular basis of inflammation-related diseases.

Contact Email

contact@eolo-pharma.com

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

MVD1

A small molecule drug candidate designed to prevent and treat obesity and its related cardiometabolic complications by stimulating energy expenditure and fat burning.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Eolo Pharma	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Eolo Pharma	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Eolo Pharma	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Eolo Pharma	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Eolo Pharma	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Eolo Pharma	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Eolo Pharma	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Eolo Pharma	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Eolo Pharma	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Eolo Pharma	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Ficus Capital	Yes	Series A - Eolo Pharma	—
Ficus Capital	Yes	Series A - Eolo Pharma	—
Ficus Capital	Yes	Series A - Eolo Pharma	—
Ficus Capital	Yes	Series A - Eolo Pharma	—
Ficus Capital	Yes	Series A - Eolo Pharma	—